Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- Check7 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the Study Details page. No substantive content changes to the study information are evident.SummaryDifference0.0%

- Check14 days agoChange DetectedThe Publications note text was updated to reflect auto-filled PubMed entries with new phrasing. There are no changes to study details or statuses.SummaryDifference0.0%

- Check21 days agoChange DetectedA new study site entry for Tainan, Taiwan was added and the existing Tainan City, Taiwan entry was removed.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedNo significant additions or deletions were detected. The page content appears unchanged.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays a funding-related operating-status notice and a new software/document version (v3.2.0), replacing the previous v3.1.0.SummaryDifference2%

- Check71 days agoChange DetectedAdded a new version label (v3.1.0) and removed several drug-safety/quality topics and an older version label (v3.0.2). Overall, this signals a version update with a cleanup of older safety-topic content.SummaryDifference0.2%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.